Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
CNOOC
00883
5
SHANGHAI PECHEM
00338
CN Stock MarketDetailed Quotes
Guangzhou Wondfo Biotech (300482)
- 18.65
- +0.13+0.70%
Market Closed Apr 28 15:00 CST
8.73BMarket Cap-52.09P/E (TTM)
18.88High18.41Low63.16KlotVolume18.52Open18.52Prev Close118.10MTurnover1.47%Turnover RatioLossP/E (Static)468.09MShares26.2952wk High1.61P/B8.02BFloat Cap17.3352wk Low22.22Limit Up430.07MShs Float83.47Historical High14.82Limit Down2.54%Range %1.80Historical Low0.40Dividend TTM18.70Avg Price27.77KlotAsk2.14%Div Yield TTM100Lot Size32.72KlotBid
Guangzhou Wondfo Biotech (300482) Cash Flow
All
YOY
| (Q1)Mar 31, 2026 | (FY)Dec 31, 2025 | (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | 7.51%586.6M | -2.75%2.46B | -6.47%1.75B | -15.02%1.13B | -23.70%545.6M | -1.75%2.52B | 2.69%1.87B | 3.84%1.34B | 8.39%715.08M | -55.57%2.57B |
| Refunds of taxes and levies | 82.60%4.72M | 155.16%19.37M | 58.09%11.32M | -53.87%2.91M | -46.62%2.58M | -55.45%7.59M | -51.49%7.16M | 224.69%6.3M | 381.79%4.84M | 20.29%17.04M |
| Net deposit increase | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Net increase in borrowings from central bank | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Net increase in placements from other financial institutions | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Cash received from interests, fees and commissions | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Net increase in repurchase business capital | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Premiums received from original insurance contracts | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Net cash received from reinsurance business | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Net increase in deposits from policyholders | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Net increase in funds disbursed | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Net cash received from trading securities | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Cash received relating to other operating activities | 22.91%10.95M | -47.21%36.36M | -60.90%26.76M | -72.02%16.58M | -61.99%8.91M | -35.43%68.88M | -34.60%68.44M | -24.24%59.25M | -49.74%23.45M | -34.26%106.67M |
| Cash inflows from operating activities | 8.11%602.27M | -3.46%2.51B | -8.14%1.79B | -17.61%1.15B | -25.06%557.1M | -3.42%2.6B | 0.27%1.95B | 2.55%1.4B | 5.08%743.37M | -54.81%2.69B |
| Goods services cash paid | -57.65%91.66M | -18.74%617.22M | -10.38%535.74M | -3.96%368.58M | 27.23%216.43M | -12.39%759.55M | -21.02%597.78M | -34.00%383.78M | -57.59%170.11M | -65.42%866.98M |
| Staff behalf paid | -37.15%173.17M | 1.04%847.74M | 9.73%687.09M | 7.71%470.19M | 3.99%275.54M | 0.91%839.05M | -2.08%626.14M | -3.85%436.52M | -7.92%264.96M | -8.74%831.52M |
| All taxes paid | -80.33%11.12M | -17.34%124.95M | -8.88%117.55M | 30.07%104.8M | 61.03%56.55M | -15.01%151.16M | -13.85%129.01M | -35.03%80.58M | -45.71%35.12M | -14.22%177.86M |
| Net loan and advance increase | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Net deposit in central bank and institutions | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Net lend capital | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Cash paid for fees and commissions | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Cash paid for indemnity of original insurance contract | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Policy dividend cash paid | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Cash paid relating to other operating activities | -31.27%108.15M | -6.45%458.18M | -6.03%397.24M | -10.91%267.2M | -1.61%157.37M | 0.27%489.77M | -2.60%422.75M | -0.62%299.92M | -8.88%159.95M | -25.22%488.43M |
| Cash outflows from operating activities | -45.59%384.1M | -8.55%2.05B | -2.14%1.74B | 0.83%1.21B | 12.02%705.89M | -5.30%2.24B | -10.32%1.78B | -17.82%1.2B | -32.18%630.14M | -44.73%2.36B |
| Net cash flows from operating activities | 246.63%218.17M | 28.01%463.04M | -69.59%52.71M | -128.11%-56.31M | -231.41%-148.79M | 10.05%361.71M | 577.95%173.32M | 311.02%200.36M | 151.07%113.22M | -80.46%328.68M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | 26.26%1.59B | 3.29%4.61B | 22.55%3.58B | 61.67%2.54B | 124.58%1.26B | 40.51%4.46B | 22.46%2.92B | -20.31%1.57B | -49.06%560.22M | -34.04%3.18B |
| Cash received from returns on investments | 89.03%18.91M | -14.51%48.7M | 7.51%35.45M | 316.50%27.48M | 75.25%10M | -4.27%56.97M | -35.12%32.97M | -85.49%6.6M | -72.75%5.71M | 4.05%59.51M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | -19.73%24.95K | 686.69%453.8K | --31.08K | --31.08K | --31.08K | -92.69%57.68K | --0 | ---- | ---- | 105.13%788.9K |
| Net cash received from disposal of subsidiaries and other business units | ---- | --1.01M | --2.86M | --1.5M | ---- | ---- | --0 | ---- | ---- | ---- |
| Cash received relating to other investing activities | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Cash inflows from investing activities | 26.75%1.61B | 3.09%4.66B | 22.48%3.62B | 62.83%2.57B | 124.09%1.27B | 39.66%4.52B | 21.26%2.95B | -21.78%1.58B | -49.51%565.93M | -33.58%3.24B |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -43.26%36.36M | -4.29%304.55M | -29.58%205.89M | -37.93%117.59M | -27.60%64.07M | -26.46%318.21M | -0.55%292.38M | -17.08%189.46M | -39.48%88.5M | -25.80%432.73M |
| Cash paid to acquire investments | 18.99%1.88B | -8.35%4.77B | -8.66%3.7B | 4.93%2.66B | 65.57%1.58B | 79.19%5.21B | 90.99%4.05B | 75.98%2.53B | -0.88%954.18M | -49.06%2.91B |
| Net cash paid to acquire subsidiaries and other business units | ---- | ---- | --0 | ---- | ---- | -5.00%10.44M | --0 | ---- | ---- | -91.98%10.99M |
| Impawned loan net increase | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Cash paid relating to other investing activities | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Cash outflows from investing activities | 16.56%1.92B | -8.29%5.08B | -10.07%3.91B | 1.95%2.78B | 57.66%1.64B | 65.27%5.54B | 79.85%4.35B | 63.24%2.72B | -5.97%1.04B | -47.93%3.35B |
| Net cash flows from investing activities | 17.82%-308.74M | 58.94%-417.46M | 79.04%-292.04M | 82.14%-204.29M | 21.20%-375.7M | -796.51%-1.02B | -7,630.93%-1.39B | -425.67%-1.14B | -4,108.11%-476.75M | 92.74%-113.4M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | ---- | ---- | --0 | ---- | ---- | 1,784.77%864.08M | 1,784.77%864.08M | 1,420.06%693.06M | --690.6M | -31.47%45.85M |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | -63.75%24.25M |
| Cash from borrowing | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Cash received relating to other financing activities | -72.64%653.1K | -63.45%7.05M | 16.34%4.74M | -3.06%3.13M | 0.07%2.39M | -37.94%19.28M | -30.27%4.07M | -30.49%3.23M | -21.72%2.39M | 24.91%31.07M |
| Cash inflows from financing activities | -72.64%653.1K | -99.20%7.05M | -99.45%4.74M | -99.55%3.13M | -99.66%2.39M | 1,048.51%883.36M | 1,579.75%868.15M | 1,285.78%696.3M | 22,641.71%692.99M | -75.70%76.91M |
| Borrowing repayment | ---- | ---- | --0 | ---- | ---- | -100.00%1.3K | --0 | ---- | ---- | 795.42%204.2M |
| Dividend interest payment | ---- | -0.85%200.58M | 1.50%205.92M | -0.68%192.57M | ---- | -13.22%202.29M | -13.02%202.87M | -14.46%193.89M | ---- | 62.53%233.1M |
| -Including:Cash payments for dividends or profit to minority shareholders | ---- | -52.00%2.94M | -57.68%2.59M | ---- | ---- | 19.05%6.13M | 19.05%6.13M | 35.03%6.13M | ---- | 75.00%5.15M |
| Cash payments relating to other financing activities | --0 | 416.24%216.81M | 801.70%184.87M | 430.97%37.77M | -82.22%160K | -76.88%42M | -43.36%20.5M | 45.17%7.11M | 28.57%900K | 58.01%181.64M |
| Cash outflows from financing activities | --0 | 70.86%417.39M | 74.95%390.8M | 14.60%230.34M | -82.22%160K | -60.53%244.29M | -52.54%223.38M | -53.55%201M | -99.56%900K | 120.12%618.94M |
| Net cash flows from financing activities | -70.67%653.1K | -164.21%-410.34M | -159.87%-386.06M | -145.87%-227.21M | -99.68%2.23M | 217.91%639.08M | 253.90%644.78M | 229.48%495.3M | 445.44%692.09M | -1,634.08%-542.02M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | -683.60%-1.39M | -130.91%-1.34M | 68.69%-266.39K | -59.02%635.7K | -85.06%237.48K | -26.31%4.33M | -109.87%-850.69K | -81.42%1.55M | 190.53%1.59M | -31.84%5.88M |
| Net increase in cash and cash equivalents | 82.51%-91.3M | -3,090.51%-366.1M | -8.62%-625.66M | -9.09%-487.17M | -258.12%-522.02M | 96.42%-11.47M | -34.54%-576M | -278.79%-446.6M | 180.15%330.15M | -294.20%-320.86M |
| Add:Begin period cash and cash equivalents | -44.21%462M | -1.37%828.1M | -1.37%828.1M | -1.37%828.1M | -1.37%828.1M | -27.65%839.58M | -27.65%839.58M | -27.65%839.58M | -27.65%839.58M | 16.60%1.16B |
| End period cash equivalent | 21.11%370.7M | -44.21%462M | -23.19%202.44M | -13.24%340.93M | -73.83%306.08M | -1.37%828.1M | -64.01%263.58M | -62.31%392.98M | 56.27%1.17B | -27.65%839.58M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
In the early hours of the 27th local time, Iran conveyed a three-phase negotiation plan to the US side, indicating that talks could resume i
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm